Ph.D. in Chemistry
The University of Texas at Austin, U.S.A.
Multi-year cross-border biopharmaceutical investment experience (China & U.S.).
Core Focus:
Innovative drugs, synthetic biology, and other cutting-edge biotechnology sectors.
Additional Background:
Investment experience in the private equity secondary market within the healthcare sector.